Clinical Trials
37 trialsNCT01164150 2026-04-13
Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Cancer Trials Ireland
Phase 2 Terminated
NCT03412630 2023-11-24
Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab
Eastern Cooperative Oncology Group
Phase NA Terminated
NCT00577317 2021-06-23
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
GOG Foundation
Phase 3 Terminated
NCT00503581 2020-11-03
Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
GOG Foundation
Phase 2 Terminated
NCT01535157 2020-08-27
Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
South Plains Oncology Consortium
Phase 1/2 Terminated
NCT01249443 2020-07-29
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
AIDS Malignancy Consortium
Phase 1 Terminated
NCT00899093 2018-05-22
YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy
GOG Foundation
Terminated
NCT01275664 2018-05-22
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
GOG Foundation
Phase NA Terminated
NCT00005029 2018-04-12
Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Terminated
NCT00096187 2018-04-12
Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
GOG Foundation
Phase 2 Terminated
NCT00574951 2018-01-11
AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Terminated
NCT00070317 2017-11-06
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
GOG Foundation
Phase NA Terminated
NCT00004221 2017-08-09
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
GOG Foundation
Phase 2 Terminated
NCT00023634 2015-03-06
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
SWOG Cancer Research Network
Phase 1 Terminated
NCT00053833 2013-11-08
S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
SWOG Cancer Research Network
Phase 2 Terminated
NCT00003378 2013-07-09
Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
GOG Foundation
Phase 1 Terminated
NCT00084448 2013-07-09
Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Terminated
NCT00002478 2013-06-10
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
GOG Foundation
Phase 2 Terminated
NCT00003179 2013-06-10
Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
GOG Foundation
Phase 2 Terminated
NCT00003380 2013-06-10
Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
GOG Foundation
Phase 1 Terminated
NCT00003382 2013-06-10
Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer
GOG Foundation
Phase 1 Terminated
NCT00003794 2013-06-10
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
GOG Foundation
Terminated
NCT00006096 2013-06-10
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva
GOG Foundation
Phase 3 Terminated
NCT00017134 2013-06-10
Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
GOG Foundation
Phase NA Terminated
NCT00002819 2013-04-11
Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer
GOG Foundation
Phase 3 Terminated
NCT00002976 2013-04-11
Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
GOG Foundation
Phase 3 Terminated
NCT00003386 2013-04-11
Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
GOG Foundation
Phase 2 Terminated
NCT00003624 2013-04-11
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
GOG Foundation
Phase 2 Terminated
NCT00004037 2013-04-11
Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Terminated
NCT00006224 2013-04-11
Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
GOG Foundation
Phase 2 Terminated
NCT00006482 2013-04-11
Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
GOG Foundation
Phase 2 Terminated
NCT00006812 2013-04-11
Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
GOG Foundation
Phase 2 Terminated
NCT00016341 2013-04-11
Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
GOG Foundation
Phase 3 Terminated
NCT00023907 2013-04-11
Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Terminated
NCT00030472 2013-04-11
Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix
GOG Foundation
Phase 2 Terminated
NCT00054067 2013-04-11
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix
GOG Foundation
Phase 3 Terminated
NCT00006356 2012-09-24
Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated